HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Iyer, R. Articles by Kushner, M. PubMed Articles by Iyer, R. Articles by Kushner, M. Social Bookmarking                         What's this?

RAVI IYER, PH.D., M.B.A., is Senior Research Analyst, Health Care Analytics, CVS Caremark, Northbrook, IL; PAULINE CODERRE, M.S., is Director, Health Management Product Development, CVS Caremark, Lincoln, RI; THERESA MCKELVEY, B.S.I.T., RN, is Clinical Care Manager, CVS Caremark, San Antonio, TX; JASON COOPER, M.S., is Vice President, Clinical Analytics, CIGNA HealthCare, Bloomfield, CT; at the time of the study he was Director, Health Management Analytics, CVS Caremark, Greensboro, NC; JAN BERGER, M.D., M.J., is President and Chief Executive Officer, Health Intelligence Partners, Chicago, IL; at the time of the study she was Senior Vice President and Chief Clinical Officer, CVS Caremark, Northbrook, IL; ELIZABETH MOORE, B.S, PHARM.D., is Clinical Pharmacist, Mountainside Hospital, Montclair, NJ; at the time of the study she was Onsite Pharmacist, Polk County Clinic, Bartow, FL; MIKE KUSHNER, CSP, ARM, HCRM, is Director, Risk Management of Polk County Government, Bartow, FL

Address correspondence to Dr. Iyer at Health Care Analytics, CVS Caremark, 2211 Sanders Road, Northbrook, IL 60062 (ravi.iyer{at}caremark.com).

Purpose. Changes in glycosylated hemoglobin (HbA1c) levels, blood pressure measurements, and utilization metrics among diabetic patients managed by a clinical pharmacist were studied. Summary. This pharmacist intervention model was developed by Polk County, Florida, to engage patients with diabetes in managing their health based on the Asheville Project’s framework. The diabetes program was implemented in February 2005, with an onsite clinical pharmacist to counsel participants with diabetes. The onsite pharmacist individualized each patient’s care. After the initial assessment, educational deficiencies were noted and addressed as needed. Outcomes measured included changes in HbA1c, blood glucose, and blood pressure values and utilization metrics, such as hospitalization and emergency room visit rates, from baseline to one year after pharmacist intervention. Of the 564 participants who enrolled in the program, 477 were enrolled at the end of one year and were included in the analysis. Results showed that HbA1c values steadily decreased over the one-year study period. At baseline, there were 55% of participants with an average HbA1c value of 7%. After one year, 72% of participants had HbA1c values of 7%. Participants’ mean systolic and diastolic blood pressure values were lower at the end of one year compared with the baseline. Participants also had a 30% reduction in hospital admissions, and the number of emergency room visits during the one-year period decreased by 24%. Conclusion. An employer-based pharmacist intervention model for patients with diabetes improved HbA1c levels, reduced systolic and diastolic blood pressure values, and decreased hospitalizations and emergency room visits after one year. Index terms: Clinical pharmacists; Clinical pharmacy; Diabetes mellitus; Interventions; Patient information; Pharmaceutical services

 

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?